Science-Driven Innovation in Dermatology Drug Development

Dermavant is a clinical-stage biopharmaceutical company focused on inflammatory skin diseases and medical dermatologic conditions. Led by its rigorous science-driven process, Dermavant has developed a pipeline that spans a broad disease state range in medical dermatology, including product candidates with multiple potential indications. Dermavant’s goal is to improve patients’ lives by developing and commercializing innovative therapies.

Strategic Collaborators

Dermavant Sciences has formed important alliances with companies who share our commitment to develop innovative dermatology drug candidates into medicines that will change the lives of patients with atopic dermatitis and other inflammatory skin diseases.